期刊文献+

基于列线图构建和验证肝细胞癌伴门静脉癌栓患者肝切除术后的预后评估模型 被引量:3

Construction and verification of the prognosis evaluation model for patients in hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy based on the nomogram
下载PDF
导出
摘要 目的分析影响肝细胞癌伴门静脉癌栓(PVTT⁃HCC)患者肝切除术后预后的影响因素,并基于列线图模型构建和验证预后评估模型。方法本研究为回顾性队列研究,选择2008年1月—2017年11月在本院行肝切除术的PVTT⁃HCC患者为研究对象,随访截至2021年1月。主要预测结局为1、3、5年总生存率。按照7∶3的比例将患者随机分为训练集和验证集,在训练集中采用Cox比例风险回归分析影响预后的影响,并基于影响因素构建列线图模型。同时在训练集和验证集中采用C⁃index评价模型的区分度,一致性曲线评估模型的校准度。结果共231例患者符合纳入排除标准纳入分析,其中训练集162例,验证集69例。Cox比例风险回归模型显示,AFP≥400μg/L、AST≥40 U/L、ALP≥80 U/L、肿瘤个数>1个及肿瘤包膜不完整是影响预后的危险因素。在训练集中,列线图模型预测1、3、5年总生存率的C⁃index分别为0.826(95%CI:0.791~0.861)、0.818(95%CI:0.782~0.854)、0.781(95%CI:0.742~0.820),在验证集中分别为0.814(95%CI:0.777~0.851)、0.798(95%CI:0.758~0.837)、0.769(95%CI:0.728~0.810)。校正曲线显示列线图模型在训练集和验证集均有较好的校准度。结论本研究构建的列线图模型可准确预测PVTT⁃HCC患者的预后。 Objective To analyze the factors affecting the prognosis of patients with hepatocellular carcinoma with portal vein tumor thrombosis(PVTT⁃HCC)after hepatectomy,and to construct and verify the prognostic evaluation model based on the nomogram model.Methods This retrospective cohort study selected patients with PVTT⁃HCC who underwent hepatectomy in Cangzhou Central Hospital from January 2008 to November 2017 as the research subjects,and the follow⁃up was as of January 2021.The main predicted outcome was the 1⁃,3⁃,and 5⁃year overall survival rates.The patients were randomly divided into training cohort and validation cohort by a ratio of 7∶3.The Cox proportional hazard regression analysis was used to analyze the impact of prognosis in the training cohort,and a nomo⁃gram model was constructed based on the influencing factors.Meanwhile,C⁃index was used to evaluate the distinction of the model in both the training cohort and the validation cohort,and the consistency curve was used to evaluate the calibration of the model.Results A total of 231 patients met the inclusion and exclusion criteria,including 162 cases of the training cohort and 69 cases of the validation cohort.The Cox proportional hazard regression model showed that AFP≥400μg/L,AST≥40 U/L,ALP≥80 U/L,number of tumors>1 and tumor envelope incompleteness were risk factors affecting the prognosis.The C⁃index of the nomogram model predicted that the 1⁃,3⁃,and 5⁃year overall survival rates were 0.826(95%CI:0.791-0.861),0.818(95%CI:0.782-0.854),and 0.781(95%CI:0.742-0.820),respectively,in the training cohort,and 0.814(95%CI:0.777-0.851),0.798(95%CI:0.758-0.837),and 0.769(95%CI:0.728-0.810),respectively,in the validation cohort.The calibration curves showed that the nomogram model had a good calibration degree in both the training cohort and the validation cohort.Conclusions The nomogram model constructed in this study can accurately predict the prognosis of patients with PVTT⁃HCC.
作者 张雷 赵秀雷 孔德帅 李金超 王振勇 刘汝海 柴伟 ZHANG Lei;ZHAO Xiulei;KONG Deshuai;LI Jinchao;WANG Zhenyong;LIU Ruhai;CHAI Wei(Department of Hepatobiliary Extra-pancreatic Surgery,Cangzhou Central Hospital,Cangzhou 061000,China)
出处 《中国癌症防治杂志》 CAS 2021年第5期518-523,共6页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 沧州市科学技术研究与发展指导计划(182302161)。
关键词 肝细胞癌 门静脉癌栓 肝切除术 列线图模型 预后 Hepatocellular carcinoma Portal vein tumor thrombus Hepatectomy Nomogram model Prognosis
  • 相关文献

参考文献5

二级参考文献33

  • 1Huang J, Hemandez-Alejand R, P. Croome K, et al. Hepatic re- section for huge ( > 15 cm) multinodular HCC with macrovascular invasion[J]. J Surg Res, 2012,178(2) :743-750. 被引量:1
  • 2Ahekruse SF, McGlynn KA, Reichman ME. Hepatocellular carci- noma incidence, mortality, and survival trends in the United States from 1975 to 2005[J]. J Clin Oncol, 2009,27(9) : 1485-1491. 被引量:1
  • 3Kaibori M, Ishizaki M, Saito T, et al. Risk factors and outcome of early recurrence after resection of small hepatoeellular carcinomas [J]. AmJSurg, 2009,198(1):39-45. 被引量:1
  • 4Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatoeellular carcinoma: prognostic and therapeutic implications[J]. Ann Surg,2006,243(2) :229-235. 被引量:1
  • 5Wang J, Li Q, Sun Y, et al. Clinicopathologie features between multicentric occurence and intrahepatic metastasis of multiple he- patocellular carcinomas related to HBV [ J]. Surg Oncol, 2009,18 ( 1 ) :25-30. 被引量:1
  • 6Ng KK, Vauthey YN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncot, 2005, 12 (5) :364-373. 被引量:1
  • 7Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma [ J ]. Gastroenterology,2008,134 ( 7 ) : 1908-1916. 被引量:1
  • 8Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes[J].J Am Coil Surgeons, 2006,202(2) :275-283. 被引量:1
  • 9Wang BW, Mok KT, Liu SI, et al. Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma? [ J ]. J Formos Med Assoc, 2008,107 (8) :616-626. 被引量:1
  • 10Raoul JL. Natural history of hepatocellular carcinoma and current treatment options. Semin Nucl Med, 2008,38 (2) : 13-18. 被引量:1

共引文献214

同被引文献26

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部